Literature DB >> 30421427

T-Helper 2 Lymphocyte Immunophenotype Is Associated With Iatrogenic Laryngotracheal Stenosis.

Alexander T Hillel1, Dacheng Ding1, Idris Samad2, Michael K Murphy3, Kevin Motz1.   

Abstract

OBJECTIVE/HYPOTHESIS: This prospective controlled human and murine study assessed the presence of inflammatory cells and cytokines to test the hypothesis that immune cells are associated with fibroproliferation in iatrogenic laryngotracheal stenosis (iLTS).
METHODS: Inflammation was assessed by histology and immunofluorescence (IF), quantitative real-time polymerase chain reaction (qRT-PCR), and flow cytometry of cricotracheal resections of iLTS patients compared to normal controls. An iLTS murine model assessed the temporal relationship between inflammation and fibrosis.
RESULTS: iLTS specimens showed increased inflammation versus normal controls (159/high power field [hpf] vs. 119/hpf, P = 0.038), and increased CD3 + T-cells, CD4 + cells, and CD3+/CD4 + T-helper (TH ) cells (all P < 0.05). The inflammatory infiltrate was located immediately adjacent to the epithelial surface in the superficial aspect of the thickened lamina propria. Human flow cytometry and qRT-PCR showed a significant increase in interleukin (IL)-4 gene expression, indicating a TH 2 phenotype. Murine IF revealed a dense CD4 + T-cell inflammatory infiltrate on day 4 to 7 postinjury, which preceded the development of fibrosis. Murine flow cytometry and qRT-PCR studies mirrored the human ones, with increased T-helper cells and IL-4 in iLTS versus normal controls.
CONCLUSION: CD3/CD4 + T-helper lymphocytes and the proinflammatory cytokine IL-4 are associated with iLTS. The association of a TH 2 immunophenotype with iLTS is consistent with findings in other fibroinflammatory disorders. The murine results reveal that the inflammatory infiltrate precedes the development of fibrosis. However, human iLTS specimens with well-developed fibrosis also contain a marked chronic inflammatory infiltrate, suggesting that the continued release of IL-4 by T-helper lymphocytes may continue to propagate iLTS. LEVEL OF EVIDENCE: NA Laryngoscope, 129:177-186, 2019.
© 2018 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Laryngotracheal stenosis; T-lymphocytes; fibrosis; human study; murine model

Mesh:

Substances:

Year:  2018        PMID: 30421427      PMCID: PMC6320294          DOI: 10.1002/lary.27321

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  41 in total

1.  Subglottic stenosis: a ten-year review of treatment outcomes.

Authors:  Anne F Hseu; Michael S Benninger; Timothy M Haffey; Robert Lorenz
Journal:  Laryngoscope       Date:  2013-10-22       Impact factor: 3.325

2.  Quantification of Inflammatory Markers in Laryngotracheal Stenosis.

Authors:  Kevin M Motz; Linda X Yin; Idris Samad; Dacheng Ding; Michael K Murphy; Madhavi Duvvuri; Alexander T Hillel
Journal:  Otolaryngol Head Neck Surg       Date:  2017-05-09       Impact factor: 3.497

3.  Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis.

Authors:  G D Sempowski; M P Beckmann; S Derdak; R P Phipps
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

4.  Mechanical force prolongs acute inflammation via T-cell-dependent pathways during scar formation.

Authors:  Victor W Wong; Josemaria Paterno; Michael Sorkin; Jason P Glotzbach; Kemal Levi; Michael Januszyk; Kristine C Rustad; Michael T Longaker; Geoffrey C Gurtner
Journal:  FASEB J       Date:  2011-09-12       Impact factor: 5.191

5.  Serial office-based steroid injections for treatment of idiopathic subglottic stenosis.

Authors:  Matthew R Hoffman; Adam R Coughlin; Seth H Dailey
Journal:  Laryngoscope       Date:  2017-06-05       Impact factor: 3.325

Review 6.  Cellular and molecular mechanisms of fibrosis.

Authors:  T A Wynn
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

7.  Antibiotics and steroids in the treatment of acquired subglottic stenosis. A canine model study.

Authors:  J S Supance
Journal:  Ann Otol Rhinol Laryngol       Date:  1983 Jul-Aug       Impact factor: 1.547

8.  Idiopathic subglottic stenosis is associated with activation of the inflammatory IL-17A/IL-23 axis.

Authors:  Alexander Gelbard; Nicolas-George Katsantonis; Masanobu Mizuta; Dawn Newcomb; Joseph Rotsinger; Bernard Rousseau; James J Daniero; Eric S Edell; Dale C Ekbom; Jan L Kasperbauer; Alexander T Hillel; Liying Yang; C Gaelyn Garrett; James L Netterville; Christopher T Wootten; David O Francis; Charles Stratton; Kevin Jenkins; Tracy L McGregor; Jennifer A Gaddy; Timothy S Blackwell; Wonder P Drake
Journal:  Laryngoscope       Date:  2016-06-14       Impact factor: 3.325

9.  A role for CD4+ T cells in the pathogenesis of skin fibrosis in tight skin mice.

Authors:  V A Wallace; S Kondo; T Kono; Z Xing; E Timms; C Furlonger; E Keystone; J Gauldie; D N Sauder; T W Mak
Journal:  Eur J Immunol       Date:  1994-06       Impact factor: 5.532

10.  Pulse steroid therapy inhibits murine subglottic granulation.

Authors:  Ankona Ghosh; Genevieve Philiponis; Jennifer Y Lee; Kevin P Leahy; Sunil Singhal; Noam A Cohen; Natasha Mirza
Journal:  Otolaryngol Head Neck Surg       Date:  2012-11-21       Impact factor: 3.497

View more
  10 in total

1.  Engineering an immunomodulatory drug-eluting stent to treat laryngotracheal stenosis.

Authors:  Madhavi Duvvuri; Kevin Motz; Michael Murphy; Michael Feeley; Dacheng Ding; Andrew Lee; Jennifer H Elisseeff; Alexander T Hillel
Journal:  Biomater Sci       Date:  2019-04-23       Impact factor: 6.843

2.  Hormone pathway comparison in non-idiopathic and idiopathic progressive subglottic stenosis.

Authors:  Ivana Fiz; Wiebke Antonopoulos; Jan-Constantin Kölmel; Karina Rüller; Francesco Fiz; Cesare Piazza; Giorgio Peretti; Christa Flechtenmacher; Peter Schirmacher; Christian Sittel
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-29       Impact factor: 3.236

3.  Increased Expression of PD-1 and PD-L1 in Patients With Laryngotracheal Stenosis.

Authors:  Ruth J Davis; Ioan Lina; Dacheng Ding; Elizabeth L Engle; Janis Taube; Alexander Gelbard; Alexander T Hillel
Journal:  Laryngoscope       Date:  2020-06-17       Impact factor: 3.325

4.  Proteomic and Genomic Methylation Signatures of Idiopathic Subglottic Stenosis.

Authors:  Stephen S Schoeff; Xudong Shi; William G Young; Chad W Whited; Resha S Soni; Peng Liu; Irene M Ong; Seth H Dailey; Nathan V Welham
Journal:  Laryngoscope       Date:  2020-07-03       Impact factor: 3.325

5.  Glutamine Inhibition Reduces Iatrogenic Laryngotracheal Stenosis.

Authors:  Hsiu-Wen Tsai; Ioan Lina; Kevin M Motz; Liam Chung; Dacheng Ding; Michael K Murphy; Michael Feeley; Jennifer H Elisseeff; Alexander T Hillel
Journal:  Laryngoscope       Date:  2021-01-12       Impact factor: 2.970

6.  Quantitative Assessment of the Immune Microenvironment in Patients With Iatrogenic Laryngotracheal Stenosis.

Authors:  Ruth J Davis; Ioan Lina; Benjamin Green; Elizabeth L Engle; Kevin Motz; Dacheng Ding; Janis M Taube; Alexander Gelbard; Alexander T Hillel
Journal:  Otolaryngol Head Neck Surg       Date:  2020-12-08       Impact factor: 5.591

Review 7.  Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults.

Authors:  Alessandro Marchioni; Roberto Tonelli; Alessandro Andreani; Gaia Francesca Cappiello; Matteo Fermi; Fabiana Trentacosti; Ivana Castaniere; Riccardo Fantini; Luca Tabbì; Dario Andrisani; Filippo Gozzi; Giulia Bruzzi; Linda Manicardi; Antonio Moretti; Serena Baroncini; Anna Valeria Samarelli; Massimo Pinelli; Giorgio De Santis; Alessandro Stefani; Daniele Marchioni; Francesco Mattioli; Enrico Clini
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

8.  Endoscopic Resection and Mucosal Reconstitution With Epidermal Grafting: A Pilot Study in Idiopathic Subglottic Stenosis.

Authors:  Ruth J Davis; Ioan Lina; Kevin Motz; Alexander Gelbard; Robert R Lorenz; Guri S Sandhu; Alexander T Hillel
Journal:  Otolaryngol Head Neck Surg       Date:  2021-07-13       Impact factor: 5.591

9.  Characterization of Fibroblasts in Iatrogenic Laryngotracheal Stenosis and Type II Diabetes Mellitus.

Authors:  Ioan Lina; Hsiu-Wen Tsai; Dacheng Ding; Ruth Davis; Kevin M Motz; Alexander T Hillel
Journal:  Laryngoscope       Date:  2020-08-28       Impact factor: 2.970

Review 10.  Inflammatory pathways in the pathogenesis of iatrogenic laryngotracheal stenosis: what do we know?

Authors:  Ruth J Davis; Alexander T Hillel
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.